Literature DB >> 23150058

The riddle of protein diagnostics: future bleak or bright?

N Leigh Anderson1, Adam S Ptolemy, Nader Rifai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23150058     DOI： 10.1373/clinchem.2012.184705

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  14 in total

1.  Bead-Based Assays for Validating Proteomic Profiles in Body Fluids.

Authors:  Annika Bendes; Matilda Dale; Cecilia Mattsson; Tea Dodig-Crnković; Maria Jesus Iglesias; Jochen M Schwenk; Claudia Fredolini
Journal:  Methods Mol Biol       Date:  2021

Review 2.  New and emerging biomarkers in cardiovascular disease.

Authors:  Leah E Cahill; Monica L Bertoia; Sarah A Aroner; Kenneth J Mukamal; Majken K Jensen
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

Review 3.  Advances and Utility of the Human Plasma Proteome.

Authors:  Eric W Deutsch; Gilbert S Omenn; Zhi Sun; Michal Maes; Maria Pernemalm; Krishnan K Palaniappan; Natasha Letunica; Yves Vandenbrouck; Virginie Brun; Sheng-Ce Tao; Xiaobo Yu; Philipp E Geyer; Vera Ignjatovic; Robert L Moritz; Jochen M Schwenk
Journal:  J Proteome Res       Date:  2021-10-21       Impact factor: 5.370

Review 4.  A critical analysis of cancer biobank practices in relation to biospecimen quality.

Authors:  Amanda Rush; Kevin Spring; Jennifer A Byrne
Journal:  Biophys Rev       Date:  2015-10-22

5.  Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9.

Authors:  Eleftherios P Diamandis; Robert C Bast; Phil Gold; T Ming Chu; John L Magnani
Journal:  Clin Chem       Date:  2012-11-30       Impact factor: 8.327

Review 6.  Development of blood biomarkers for drug-induced liver injury: an evaluation of their potential for risk assessment and diagnostics.

Authors:  David E Amacher; Shelli J Schomaker; Jiri Aubrecht
Journal:  Mol Diagn Ther       Date:  2013-12       Impact factor: 4.074

7.  Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma.

Authors:  Alok K Shah; Kim-Anh Lê Cao; Eunju Choi; David Chen; Benoît Gautier; Derek Nancarrow; David C Whiteman; Nicholas A Saunders; Andrew P Barbour; Virendra Joshi; Michelle M Hill
Journal:  Mol Cell Proteomics       Date:  2015-09-24       Impact factor: 5.911

8.  Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer.

Authors:  Fabian Coscia; Ernst Lengyel; Jaikumar Duraiswamy; Bradley Ashcroft; Michal Bassani-Sternberg; Michael Wierer; Alyssa Johnson; Kristen Wroblewski; Anthony Montag; S Diane Yamada; Blanca López-Méndez; Jakob Nilsson; Andreas Mund; Matthias Mann; Marion Curtis
Journal:  Cell       Date:  2018-09-20       Impact factor: 41.582

Review 9.  Revisiting biomarker discovery by plasma proteomics.

Authors:  Philipp E Geyer; Lesca M Holdt; Daniel Teupser; Matthias Mann
Journal:  Mol Syst Biol       Date:  2017-09-26       Impact factor: 11.429

10.  Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona.

Authors:  John E Blume; William C Manning; Gregory Troiano; Daniel Hornburg; Michael Figa; Lyndal Hesterberg; Theodore L Platt; Xiaoyan Zhao; Rea A Cuaresma; Patrick A Everley; Marwin Ko; Hope Liou; Max Mahoney; Shadi Ferdosi; Eltaher M Elgierari; Craig Stolarczyk; Behzad Tangeysh; Hongwei Xia; Ryan Benz; Asim Siddiqui; Steven A Carr; Philip Ma; Robert Langer; Vivek Farias; Omid C Farokhzad
Journal:  Nat Commun       Date:  2020-07-22       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.